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ABSTRACT 
 
SARAH T. CLEMENT: Regulation of G protein signaling by G protein alpha subunit 
phosphorylation 
(Under the direction of Dr. Henrik G. Dohlman) 
 
Cells respond to stimuli by detecting extracellular signals in complex 
environments through cell membrane protein receptors. G protein coupled receptors 
(GPCRs) comprise the largest family of plasma membrane receptors and transduce 
signals from an array of stimuli including light, odors, hormones and 
neurotransmitters. GPCR-mediated pathways are important in many physiological 
functions and are targeted by numerous pharmaceuticals. Thus a comprehensive 
understanding of the regulation of GPCR-mediated pathway components is 
necessary to achieve full therapeutic effectiveness and discover new drug targets. 
This work examines how GPCR-mediated signaling pathways are modulated in the 
context of changes in the cell-cycle and changes in nutrient availability.  
In this thesis, we present studies to identify new regulators of G protein 
signaling. Specifically, we show that the G protein α subunit, Gpa1, is 
phosphorylated and degraded in a cell-cycle dependent manner. In addition, we 
demonstrate that Gpa1 is phosphorylated in a low glucose-dependent manner, 
which leads to a reduction in signal transduction. These findings reveal new 
regulatory and cross talk functions in signal transduction pathways. Furthermore, the 
work in this thesis has expanded our understanding of G protein signaling networks 
and the mechanisms by which concurrent signals are prioritized and coordinated. 
	  iv 
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CHAPTER I 
 
INTRODUCTION* 
 
Cells respond to stimuli by detecting their extracellular environment through 
cell membrane protein receptors. One such family of receptors, the G protein 
coupled receptors (GPCRs), is responsible for the transduction of numerous signals 
including light, odors, hormones and neurotransmitters. GPCRs are important 
mediators of signaling pathways in numerous tissues in the body, including the heart 
and brain, and often aberrant signaling can lead to disease. GPCRs are commonly 
used drug targets, making up a third of drugs on the market (15, 50, 62). These 
drugs aimed at modulating signaling pathways include anti-depressants, anti-
histamines, and beta-blockers for the treatment of many diseases and ailments such 
as heart disease, schizophrenia, and allergies. As research leads to a more 
comprehensive understanding of GPCR-mediated protein signaling pathways, it is 
expected to lead to the identification of new drug targets and the generation of new 
pharmaceuticals and alternative drug regimens. 
 Cells often encounter multiple extracellular cues, which can often be in 
conflict with each other. While there is much known about how extracellular signals 
activate GPCRs and downstream G protein signaling, less is known about how 
GPCR-mediated pathways are altered when multiple extracellular signals are 
                                            
* All figures contributed by Sarah T. Clement 
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received and concurrent pathways are activated. This thesis work examines the 
convergence of two signaling pathways long thought to act separately: a GPCR-
mediated pathway and the metabolism-regulating AMP-activated protein kinase 
(AMPK) pathway. More broadly, this work demonstrates the importance of crosstalk 
between signaling pathways to coordinate and elicit an appropriate cellular response 
when cells encounter complex extracellular environments. 
 
Heterotrimeric G proteins 
GPCRs are ubiquitously found in yeast, plants and animals. GPCRs are 
coupled to heterotrimeric G proteins, which consist of a G protein α subunit and a G 
protein βγ obligate dimer. Once an agonist binds to the GPCR, the receptor 
becomes activated and acts as a guanine nucleotide exchange factor (GEF) leading 
to the exchange of GDP for GTP on the Gα subunit. The activation of Gα leads to 
dissociation from Gβγ, and both are free to bind downstream effectors leading to 
consequences such as the production of second messengers and the activation of 
protein kinase cascades. Signaling stops when GTP is hydrolyzed to GDP, which is 
often accelerated through GTPase activating proteins (GAPs), and the subunits 
rebind to form the heterotrimeric complex (53).  
The Gα subunits are the first proteins activated downstream of GPCRs and 
can be grouped into four family subtypes Gαs, Gαi, Gαq and Gα12/13, which mediate 
common downstream activities (45) (Fig. 1.1). Gαs family members are linked to 
cAMP second messenger production through the activation of adenylyl cyclase, 
whereas Gαi inhibits adenylyl cyclase. Gαq family members are linked to activation of 
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4 
phospholipase C and the production of diacylglycerol (DAG) and inositol 
triphosphate (IP3) second messengers. Finally, the Gα12/13 family members can 
regulate small GTPase Rho activity via activation of RhoGEF proteins. While it is 
well-known that extracellular GPCRs are good targets for pathway modulation, the 
intracellular Gα subunits are poised to be good targets for regulation as the first 
components in G protein signaling cascades. 
 
Yeast as a Model Organism for Studying G Protein Signaling 
Saccharomyces cerevisiae has proven to be a very useful model organism for 
studying conserved signaling pathways. In 1996, Saccharomyces cerevisiae 
became the first eukaryotic genome to be sequenced (22), thus facilitating genome-
based screens and studies. The founding members of many important proteins have 
been first found independently in yeast including the master metabolic regulator 
AMP-activated kinase (Snf1) (8), regulator of G protein signaling protein (Sst2) (13), 
aging-related sirtuin protein (Sir2) (33), p21-activated kinase (Ste20) (37), vesicle-
fusion SNARE proteins (48), cell division cycle proteins (Cdc) (24), and the 
nucleosome-remodeling SWI/SNF complex (61). Yeast is tractable to numerous 
genetic techniques, including complete gene deletions and targeted point mutations 
of endogenous proteins. In 2000, the Saccharomyces Genome Deletion Project 
released the Yeast Knock-Out deletion collection, which included almost 82% of all 
yeast genes (20, 61). 
Yeast contain a canonical G protein-signaling pathway linked to a MAP 
kinase cascade. Unlike humans, whose genomes encode hundreds of GPCRs and 
5 
16 Gα subunits, yeast contain 3 GPCRs and 2 Gα subunits (4, 27). Thus yeast 
contains a simplified system for studying evolutionarily similar proteins and their 
signaling responses. Diploid and haploid yeast can proliferate stably, which easily 
allow the study of recessive gene mutations. Haploid yeast exist in two mating types, 
type a cells (MATa) and type alpha cells (MATα). Small peptide pheromones are 
released when cells of opposite mating type are in proximity to one another. MATa 
releases a-factor pheromone and MATα releases α-factor pheromone. The 
pheromone ligands can bind to GPCRs on opposite cell mating types and activate G 
protein signaling cascades to prepare the cells for fusion to form an a/α diploid cell 
(3).  
 
The Pheromone Response Pathway 
The pheromone response or mating pathway in the yeast Saccharomyces 
cerevisiae is a prototypical GPCR-mediated pathway. The pheromone response 
pathway has been used as a model to study signaling events, as many proteins in 
this pathway are functionally conserved in higher organisms. The response to 
pheromone ligand α-factor binding the GPCR Ste2 on a MATa cell, includes 
activation of a Gαi protein Gpa1 and a protein kinase cascade comprised of Ste20, 
Ste11, Ste7 and two partially redundant MAP kinases Fus3 and Kss1. The activation 
of the MAP kinases results in upregulated mating gene transcription, morphological 
changes, and growth arrest for the haploid cells to prepare for fusion and form a 
diploid cell (14) (Fig. 1.2).  
While the key components of the yeast pheromone pathway have been 
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known for years, questions still remain about how sensitivities, amplitudes, and 
temporal aspects of adaptive responses are controlled. Of particular interest is when 
concurrent extracellular signals received by the cell have potentially contradictory 
outcomes. 
This work focuses on the regulation and modification of the G protein α 
subunit in the mating pathway as a means of pathway regulation. The list of G 
protein-binding partners and post-translational modifications has expanded in recent 
years. It is well known that Gpa1 binds to a pheromone receptor Ste2 (5), the Gβγ 
subunit pair Ste4/Ste18 (11), and a GTPase accelerating protein Sst2 (2). Other 
identified binding partners for Gpa1 include a non-receptor exchange factor (Get3) 
and two subunits of the phosphatidylinositol 3-kinase (Vps15 and Vps34). 
Additionally, binding partners of Gpa1 include the enzymes responsible for the 
addition or removal of post-translational modifications. These include a N-
myristoyltransferase Nmt1 (17), a palmitoyltransferase (32), a de-palmitoylating acyl-
protein thioesterase Apt1 (16), a ubiquitin ligase Rsp5 (Gpa1 monoubiquitination) 
(57), and a ubiquitin ligase SCF Cdc4 (Gpa1 polyubiquitination) (7) (Fig. 1.3). These 
modifications are often dynamic and directly contribute to the ability of Gpa1 to 
maintain signaling fidelity during mating response. 
The work in this thesis reveals that Gpa1 is also modified by phosphorylation. 
Gpa1 joins a small but growing list of phosphorylated G protein α subunits. In most 
cases the consequences of G protein phosphorylation are not well understood, but 
seem to affect signal amplitude and duration. Consequences of G protein α subunit 
phosphorylation include loss of interaction with G protein βγ subunits (35), loss of 
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interaction with RGS (21), loss of guanine nucleotide binding (47), receptor 
desensitization (10, 52), and loss of interaction with downstream effectors (41).  
 
Energy-sensing AMPK 
All cells and organisms must monitor and maintain their energy levels for  
survival. AMP-activated kinases (AMPKs) are major metabolic regulators in 
eukaryotes. These kinases serve as molecular switches to turn on ATP-generating 
catabolic pathways while suppressing ATP-consuming anabolic pathways in energy-
poor or other stress conditions (55). AMPK consists of a protein complex encoded 
by three subunits, a serine-threonine kinase catalytic subunit (α) and two regulatory 
subunits (β, γ). When AMPK signaling is disrupted, cells can eventually undergo cell 
death due to lack of signal reprogramming in starvation conditions. Signaling 
networks initiated by AMPKs are implicated in a variety of human diseases including 
diabetes, lipid disorders, and cardiovascular disease (59).  
Yeast protein Snf1 is the founding member of the AMPK family. Snf1 was first 
identified genetically in screens for mutants deficient in the utilization of carbon 
sources other than glucose (SNF1, sucrose non-fermenting) (8). It was shown 
subsequently that a reduction in extracellular glucose leads to rapid activation of 
Snf1 (60, 64) and the de-repression of genes involved in utilization of alternative 
sugars and gluconeogenesis (38). Yeast contain one catalytic α subunit (Snf1), three 
β subunits (Sip1, Sip2, or Gal83) and one nucleotide-binding γ subunit (Snf4) (9, 31, 
43, 65) (Fig. 1.4). Activation of Snf1 requires phosphorylation of Thr-210 in the 
activation loop (18). The three partially redundant kinases, Elm1, Sak1, and Tos3, 
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activate Snf1 by phosphorylation (28). Notably, in support of yeast as a valuable 
model system, the identification of the Snf1-activating kinases in yeast (28, 56) 
quickly led to the discovery of the mammalian AMPK kinases (25, 30, 63). 
The protein phosphatase complex Glc7/Reg1 mediates dephosphorylation of 
Snf1 (40, 44, 51). Glc7 is the catalytic subunit of the phosphatase complex whereas 
Reg1 is the regulatory subunit that targets Glc7 to substrates. Glc7 has numerous 
other substrates, which are targeted by a variety of regulatory subunits (19, 34, 36, 
39). Yeast are inviable without Glc7, so the deletion of REG1 is used to uncouple 
Glc7 phosphatase activity towards Snf1. In the absence of Reg1, the Snf1 complex 
is constitutively active resulting in loss of glucose repression (29, 44, 58). 
 The phosphorylation (activation) status of the kinase Snf1 is a balance 
between upstream kinases/phosphatase activity and active site availability. In 
energy-rich conditions, Snf1 exists in an unphosphorylated state because the rate of 
phosphate removal by Glc7/Reg1 exceeds the rate of phosphate addition by Elm1, 
Sak1, and Tos3 (49). In glucose stress conditions, Snf1 is phosphorylated because 
the regulatory Snf4 subunit binds to two molecules of ADP and protects Snf1 from 
dephosphorylation (42). Consequently, Snf1 persists in an activated state until ATP 
levels are restored. This mechanism of regulation is conserved in mammals (1). 
 An ongoing question in the field is why there exists three ‘redundant’ 
upstream kinases for Snf1. Indeed, deletion of all three kinases is needed to abolish 
Snf1 activity and result in a snf1Δ phenotype (28). There are some subtle 
differences between upstream kinases in terms of Snf1 activation, with Sak1 thought 
to be the primary Snf1 kinase. Sak1 as the primary kinase for Snf1 is based on 
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findings that Sak1 is the only upstream kinase to be found in a stable complex with 
Snf1 (18). In addition, cell lysates purified from strains expressing each upstream 
kinase individually showed Snf1 had the highest activity toward a peptide substrate 
in the strain containing only Sak1 (26, 28). While Sak1 and Tos3 have only been 
shown to function as Snf1 kinases, Elm1 has been shown to have other functions 
besides Snf1 metabolism regulation. Elm1 also has regulatory functions involving 
cell morphology, filamentous invasive growth, and control of bud growth and 
cytokinesis (6, 54). Studies have shown that the differences between the Elm1, 
Sak1, and Tos3 kinases are dependent on the type of carbon source stress and the 
different isoforms of the Snf1 kinase complex (43). It is likely that novel functions and 
substrates exist that will, if identified, further define the differences between these 
kinases. 
 
Cross talk between signaling pathways 
One common approach to studying most signaling pathways is to model the 
protein components in a linear fashion. Often, as more research is conducted, new 
connections become apparent that are not linear but rather serve as positive or 
negative feedback loops. The reality is that these pathways are not isolated. Cells 
have numerous receptors sensing an ever-changing extracellular environment. 
Thus, numerous pathways are signaling at any given time. Why do signaling 
pathways contain so many protein components? Wouldn’t it be more efficient to 
have fewer components between the extracellular signal and the transcriptional 
response in the nucleus? These multiple components in signaling cascades likely 
serve as points of regulation between parallel signaling cascades. Cross talk 
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between pathways provides a means to tune and prioritize signaling responses.  
Cross talk can mediate responses to attenuate or strengthen two signaling 
pathways. For example, previous work by Nagiec et al. examined cross talk between 
the mating pathway and the hyperosmotic stress pathway in yeast (46). Cells were 
treated simultaneously with pheromone and salt, and monitored for pheromone 
response. Under these circumstances, Nagiec et al. observed an attenuation of the 
mating pathway, as determined by quantitative mating assays, microscopic 
assessment of mating projection morphology, dampened mating transcriptional 
response and dampened MAPK activation. In this case the mating pathway and 
hyperosmotic stress pathway share signaling components. Thus, the mechanism by 
which cross talk dampens the mating pathway is complex and acts on multiple 
pathway components, where some are shared and some are not. Another example 
where one pathway antagonizes another is in the Protein Kinase A (PKA) and MAPK 
pathways in human arterial smooth muscle cells (23). Cells were treated with 
platelet-derived growth factor (PDGF) to activate the PDGF receptor and MAPK 
signaling cascade and also treated with agonists such as isoproterenol to activate 
PKA and cAMP signaling. The activities of MAPK and PKA were monitored and it 
was determined that MAPK was antagonized by PKA activation but not vice versa. 
The point of antagonism was narrowed down to proteins associated with the PDGF 
receptor. As mentioned, cross talk may also be desirable in order to strengthen an 
appropriate cellular response. Indeed, it is critical that growth factor signals and cell 
adhesion signals are well-coordinated, in regard to aberrant signaling in cancer and 
metastasis (12). These examples of cross talk highlight the importance of 
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communication between signaling cascades. In this age where patients are taking 
numerous drugs for multiple ailments, it is crucial to investigate cross talk between 
pharmaceutically-targeted signaling pathways. 
 
Summary 
The remainder of this thesis is divided into 3 chapters. In Chapter II, “Cell 
cycle-dependent phosphorylation and ubiquitination of a G protein α subunit,” I 
present a screen of a kinase gene deletion library to determine the Gpa1 kinase. 
Also in chapter II, I show how we determined that Gpa1 phosphorylation by Elm1 
occurs in a cell cycle-dependent manner and leads to polyubiquitination and 
destruction of Gpa1. In Chapter III, “Regulation of a G protein by AMPK/Snf1 
kinases,” I examine how Gpa1 is phosphorylated in response to glucose limitation 
and causes dampened GPCR-mediated signaling. Finally, in Chapter IV, 
“Conclusions and General Discussion,” I discuss the broad impact of these findings 
and speculate on the future direction of the field. 
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CHAPTER II 
 
 
CELL CYCLE-DEPENDENT PHOSPHORYLATION AND UBIQUITINATION OF A G 
PROTEIN α SUBUNIT*Φ 
 
 
A diverse array of external stimuli, including most hormones and 
neurotransmitters, bind to cell surface receptors that activate G proteins. Mating 
pheromones in yeast Saccharomyces cerevisiae activate G protein-coupled 
receptors and initiate events leading to cell cycle arrest in G1 phase. Here, we show 
that the Gα subunit (Gpa1) is phosphorylated and ubiquitinated in response to 
changes in the cell cycle. We systematically screened 109 gene deletion strains 
representing the non-essential yeast kinome and identified a single kinase gene, 
ELM1, as necessary and sufficient for Gpa1 phosphorylation. Elm1 is expressed in a 
cell cycle-dependent manner, primarily at S and G2/M. Accordingly, phosphorylation 
of Gpa1 in G2/M phase leads to polyubiquitination in G1 phase. These findings 
demonstrate that Gpa1 is dynamically regulated. More broadly, they reveal how G 
proteins can simultaneously regulate, and become regulated by, progression 
through the cell cycle. 
                                            
* Elements of the work referenced in this chapter have been published in: Torres MP, Clement ST, 
Cappell SD, and Dohlman HG. (2011) Cell cycle-dependent phosphorylation and ubiquitination of a G 
protein α subunit. J Biol Chem. 286, 20208-16. 
 
Φ I am including this work in my thesis as I am a co-author on this publication. I performed the initial 
kinome screen, which lead to the examination of Elm1 as a potential kinase for Gpa1. I also 
conducted some preliminary functional assays with the elm1Δ strain. Matt Torres conducted the rest 
of the experiments included in this paper and wrote the majority of the paper, with input from all 
authors.  
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Introduction 
G protein coupled receptors and heterotrimeric G proteins are the 
predominant components through which cells receive and transduce extracellular 
signals. G protein signal transduction is highly conserved throughout eukaryotes, 
including the yeast Saccharomyces cerevisiae. In yeast, haploid a-type cells secrete 
an a-factor pheromone that binds to receptors on the surface of α-type cells, 
whereas α-type cells secrete an α-factor that acts exclusively on a-type cells (13). 
Consequently, the haploid cells fuse to form an a/α diploid cell. 
  As with other G protein systems, activation of the yeast pheromone receptor 
stimulates exchange of GDP for GTP on the G protein α subunit (Gpa1), which 
promotes its dissociation from the Gβγ (Ste4/18) heterodimer (13, 44). In yeast, Gβγ 
is primarily responsible for transmission and amplification of the signal to effector 
proteins, whereas the Gα serves primarily to regulate the levels of free Gβγ. As a 
consequence, cells are highly sensitive to small changes in the stoichiometry of Gα 
and Gβγ (5, 7, 43). The signal is terminated by hydrolysis of GTP to GDP on the Gα 
subunit, which promotes reassociation of the heterotrimeric G protein complex. 
Further regulation is imposed by accelerating the GTPase activity of Gα via 
regulators of G protein signaling proteins (21). 
 Propagation of the G protein signal requires components of a MAPK cascade 
(Ste20, Ste11, Ste7, Fus3 or Kss1), a MAPK scaffold (Ste5), as well as a 
transcription factor (Ste12) (13). Consequently, the pheromone initiates changes in 
gene expression and cell morphology that prepare the cell to undergo cell-cell and 
nuclear fusion. Critical to this process is the initiation of cell cycle arrest in G1 phase, 
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which ensures that each haploid cell contains one copy of every chromosome before 
fusion (61). Pheromone-induced G1 arrest necessarily prevents fusion during DNA 
replication (S phase) or before mitosis (M phase), during which nuclear fusion could 
lead to missegregation of genetic material, aneuploidy, and other proliferative 
disadvantages (51, 52). Consequently, yeast mating and cell cycle progression must 
be highly coordinated processes. 
 The mating pathway is well known to regulate the cell cycle by stimulating the 
expression of Far1, a cyclin-dependent kinase inhibitor that arrests cells at START in 
late G1 phase (34, 36, 38, 39, 55). Reciprocally, Far1 is itself regulated in a cell-cycle 
dependent manner and is degraded after cells pass through START and exit G1 
phase (34, 38). Degradation of Far1 is initiated in G1 by cyclin-dependent kinase-
mediated phosphorylation, which promotes its ubiquitination by the SCF 
(Skp1/Cullin/F-box) ubiquitin ligase (3, 20, 36). 
 Emerging evidence suggests that multiple mating pathway components are 
regulated by ubiquitination. Targets of ubiquitin-mediated degradation include the 
regulator of G protein signaling protein Sst2 (18), the MAPK kinase Ste7 (56), the 
MAPK scaffold protein Ste5 (16), and the G protein α subunit Gpa1 (31, 32, 54, 57). 
Of these, the SCF has been shown to be necessary and sufficient for ubiquitination 
of Gpa1 (5). While SCF substrates are generally phosphorylated prior to 
ubiquitination (10, 60), as yet the kinase that phosphorylates Gpa1 has not been 
identified. 
 Here we identify a novel G protein kinase, Elm1. We show that the G protein 
is phosphorylated directly by Elm1 and that phosphorylation occurs in coordination 
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with Elm1 expression during the cell cycle. G protein phosphorylation in G2/M phase 
leads to ubiquitination during the following G1 phase. In the absence of Elm1, the G 
protein is neither phosphorylated nor ubiquitinated. Taken together, these findings 
show how G proteins can simultaneously regulate, and become regulated by, 
progression through the cell cycle. 
 
Results 
 Gpa1 Is A Phosphoprotein - Gpa1 undergoes a variety of post-translational 
modifications including myristoylation, palmitoylation, and ubiquitination (32, 58). 
The myristoylation state of Gpa1 can be distinguished by an electrophoretic mobility 
shift following SDS-PAGE and immunoblotting. Because only a fraction of Gpa1 has 
shifted mobility under these conditions, the prevailing view has been that Gpa1 
exists in both myristoylated and non-myristoylated states (46). However, upon close 
inspection of the overexpressed protein, we found that even non-myristoylated 
Gpa1G2A exhibits differential mobility shift by immunoblotting, indicating the presence 
of another modification (Fig. 2.1 A). Given that phosphorylation can likewise alter the 
electrophoretic mobility of proteins, we asked whether phosphorylation rather than 
myristoylation might account for the second form of Gpa1. Consistent with this 
hypothesis, phosphatase treatment of whole cell extracts (Fig. 2.1 B) or of purified 
Gpa1 (Fig. 2.1 C) resulted in a complete loss of the slower migrating form of Gpa1. 
We also found that a mutation of serine 200, which was identified as a 
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phosphorylation site by mass spectrometry (28), altered the mobility of Gpa1. 
Substitution of Ser-200 with alanine (S200A) or glutamate (S200E) replicated the 
mobility of dephosphorylated and phosphorylated Gpa1, respectively (Fig. 2.1 D). 
We conclude that Gpa1 is a phosphorylated protein. 
 A Yeast Kinome Screen Reveals Elm1 as a G Protein Kinase - To identify the 
Gpa1 kinase, we monitored the phosphorylation-dependent mobility shift of 
endogenously expressed Gpa1 in gene deletion strains representing the majority of 
the yeast kinome. Of the 109 strains tested, deletion of ELM1 alone resulted in a 
significant observable loss of phosphorylated Gpa1 (Fig. 2.2).  Phosphorylation of 
Gpa1 was restored by plasmid-borne expression of ELM1 (Fig. 2.3 A). We observed 
no such differences in the absence of kinases that act downstream of Elm1 or that 
are functionally similar to Elm1 (see discussion, Fig. 2.2) (1, 45). We conclude that 
Elm1 phosphorylates Gpa1 in vivo. 
 Elm1 Is Required for Maximal Pheromone-induced Gene Transcription - Elm1 
is best known as a regulator of cell morphology during G2/M phase of the cell cycle. 
During G2/M, Elm1 phosphorylates proteins required for the morphogenesis 
checkpoint that coordinates bud emergence and mitosis (8, 49) as well as 
organization of septins during cytokinesis (1, 4, 45). Yeast harboring elm1 mutations 
exhibit morphologically distinct growth pattern in which cells delay cytokinesis and 
undergo elongated bud growth, a process that also occurs under conditions or 
nitrogen starvation and filamentous growth (26). Elm1 has been proposed to inhibit 
the filamentous growth response that includes multiple signaling branches, including 
the MAP kinases Ste20, Ste11, Ste7, and Kss1 (26, 37), all of which participate as 
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well in the pheromone response pathway. Accordingly, we found that Kss1 was 
more highly expressed and activated in elm1Δ cells compared to wild-type cells (Fig. 
2.3 B). In addition, deletion of KSS1 in elm1Δ cells reduced filamentous-like 
phenotype (elongated buds and flocculation) typical of elm1Δ cells (Fig. 2.3 C). In 
contrast, the other pheromone-responsive MAP kinase Fus3 was largely unaffected 
by the absence of Elm1 (Fig. 2.3 B).  
 We next determined whether Elm1 regulates pheromone-dependent gene 
transcription using a β-galactosidase reporter fused with the promoter of the mating-
specific gene FUS1. We found that elm1Δ cells exhibit a significantly reduced 
maximum level of pheromone-induced gene transcription. Signaling was restored 
upon plasmid-borne expression of wild-type Elm1 but not kinase-inactive Elm1K177R 
(Fig. 2.3 D). Thus, Elm1 represses activation of the MAP kinase branch of the 
filamentous growth response, including Kss1, and is required for maximal response 
to the mating pheromone. 
Gpa1 is phosphorylated directly by Elm1 - Elm1 clearly plays a role in multiple 
signaling pathways, including the filamentous growth and pheromone response 
pathways, any of which could be indirectly responsible for the diminished Gpa1 
phosphorylation in elm1Δ cells. Therefore, we asked whether Elm1 acts directly on 
Gpa1. We established that purified Elm1 could bind to and phosphorylate 
recombinant Gpa1 in vitro (Fig. 2.4). Elm1 is also capable of autophosphorylation 
(26), and we show that this activity is exhibited in GST-Elm1 (Fig. 2.4 A-C). Both 
Elm1 autophosphorylation and Gpa1 transphosphorylation were blocked when 
catalytically inactive GST-Elm1K177R was substituted for the wild-type kinase (Fig. 2.4 
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A). Consistent with our findings in vivo, Ser-200 is required for maximum 
phosphorylation of Gpa1 (Fig. 2.4 B). Similar results were observed upon mutation 
of all 15 Ser and Thr residues in the ubiquitination domain (data not shown). Finally, 
Elm1 was able to bind to, but not effectively phosphorylate, Gpa1ΔUD, a mutant that 
lacks the ubiquitination domain of the protein (residues 129-236) (Fig. 2.4 C and D). 
We conclude that Elm1 phosphorylates Gpa1 directly at serine 200 and other 
multiple other sites throughout the protein. 
Gpa1 Phosphorylation is Cell Cycle-dependent – We next determined how 
phosphorylation of Gpa1 is regulated. Elm1 is expressed primarily during S and 
G2/M phases of the cell cycle (4, 26, 37). Further, longstanding evidence indicates 
that the mobility-shifted (phosphorylated) form of Gpa1 is significantly reduced upon 
pheromone stimulation (12), which induces cell cycle arrest in G1 phase. Thus, we 
considered whether Gpa1 phosphorylation is regulated during the cell cycle. We 
directly compared Gpa1 from cells arrested in G1 phase with α-factor (α-F), in S 
phase with hydroxyurea (HU), or in G2/M phase with nocodazole (Nz). Hydroxyurea 
inhibits deoxyribonucleotide synthesis, inducing a DNA replication checkpoint arrest 
in S phase (59). Nocodazole inhibits microtubule polymerization and induces a 
checkpoint arrest at the metaphase/anaphase transition of mitosis (25). We found 
that phosphorylated Gpa1 is most abundant in cells arrested in S and G2/M, but 
lowest in cells arrested in G1 phase (Fig. 2.5 A). To determine the dynamics of 
phosphorylation during the cell cycle, we monitored Gpa1 during arrest and release 
in cells treated with nocodazole or hydroxyurea. To validate the arrest and release 
protocol, we monitored changes in the mitotic cyclin Clb2 (9). We found that 
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phosphorylated Gpa1 accumulates in a coordinated fashion with Clb2 as cells arrest 
in either G2 /M or S phase (Fig. 2.5, B and D). Upon release from nocodazole, 
phosphorylated Gpa1 and Clb2 rapidly decrease in abundance and then increase 
concomitantly as cells reenter the cell cycle (Fig. 2.5 C). Similar coordination 
between phosphorylated Gpa1 and Clb2 was evident in cells released from 
hydroxyurea induced cell cycle arrest (Fig. 2.5 E). Finally, we observed temperature-
dependent accumulation of phosphorylated Gpa1 in cdc6–1ts cells, which are 
incapable of DNA replication licensing, resulting in a post-START arrest in late 
G1/early S phase (Fig. 2.5 A) (29, 30). We conclude that Gpa1 phosphorylation is 
Elm1-dependent and cell cycle-regulated. Although phosphorylated Gpa1 
accumulates throughout the S and G2/M phases, it is rapidly eliminated from cells 
during G1 phase. 
Elm1 Is Required for Gpa1 Polyubiquitination - We have shown previously 
that Gpa1 is polyubiquitinated by the SCFCdc4 ubiquitin ligase (5) and that 
ubiquitination occurs primarily at lysine 165 within the ubiquitinated subdomain of 
Gpa1 (32). Typically, SCF recruits phosphorylated proteins as substrates for 
ubiquitination (10, 60). Therefore, we asked whether Elm1 phosphorylation promotes 
Gpa1 polyubiquitination. We compared Gpa1 polyubiquitination in the presence and 
absence of ELM1 using a proteasome-deficient yeast strain, cim3–1 (54, 57). For 
these experiments, Gpa1 was overexpressed to allow detection of the minor 
ubiquitinated species. Growth of cim3–1 cells at the restrictive temperature 
inactivates Cim3, an essential protein component of the 26 S proteasome (15), 
thereby stabilizing polyubiquitinated proteins and further enabling their detection by 
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immunoblotting. Consistent with the hypothesis, Gpa1 polyubiquitination is 
considerably diminished in the absence of Elm1 or in the presence of plasmid-borne 
Elm1K117R (Fig. 2.6). To validate the observations made in cim3–1 cells, we also 
monitored Gpa1 polyubiquitination in wild type or elm1Δ cells expressing myc-
ubiquitin (proteins conjugated to myc-ubiquitin are degraded slowly) (14, 22). Once 
again Gpa1 polyubiquitination was diminished in the absence of Elm1. We conclude 
that Elm1 is required for ubiquitination, as well as for phosphorylation, of Gpa1. 
Gpa1 Ubiquitination Is Regulated during the Cell Cycle - Phosphorylation is a 
well-established precursor to ubiquitination by the SCF (60) and serves as a signal 
for recruitment of target substrates by F-box proteins (42). Our previous findings 
indicate that Gpa1 is ubiquitinated by SCFCdc4. The data presented above indicate 
that Gpa1 is phosphorylated by Elm1 and that Elm1 is required for ubiquitination. 
Therefore, we postulated that phosphorylation by Elm1 precedes ubiquitination by 
SCF. To test this hypothesis, we compared the relative proportion of phosphorylated 
Gpa1 in cells lacking functional Cdc4 (F-box protein) or Cdc34 (ubiquitin-conjugating 
enzyme), which we previously identified as responsible for polyubiquitination of 
Gpa1 (5). Accordingly, we monitored Gpa1 in temperature-sensitive cdc4-1 and 
cdc34-2 mutants (27). Consistent with the hypothesis, we found the proportion of 
phosphorylated Gpa1 to be higher in asynchronous cells lacking active forms of 
either Cdc4 or Cdc34 but comparatively lower in identically treated wild-type cells 
(Fig. 2.7 A, left panel). Similar results were obtained using Tet-repressible versions 
of CDC4 and CDC34 (data not shown). Thus, phosphorylated Gpa1 accumulates in 
the absence of functional SCFCdc4 ubiquitin ligase. Finally, we considered whether 
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ubiquitination, in addition to phosphorylation, might be regulated by the cell cycle. In 
support of this model, accumulation of phosphorylated Gpa1 in SCF-deficient cells is 
comparable with that observed in G2/M arrested cells (Fig. 2.7 A, right panel). 
Moreover, we found that Gpa1 polyubiquitination is significantly higher in cells 
arrested in G1 phase with α-factor mating pheromone or by temperature inactivation 
of cdc28-1 when compared with cells arrested in S phase or in G2/M phase (Fig. 2.7, 
B and C). Although treatment with α-factor results in Far1-mediated G1 arrest, cells 
expressing cdc28-1 undergo G1 arrest independent of pheromone pathway 
activation at the restrictive temperature (35). In either case, Gpa1 polyubiquitination 
is highest in cells arrested in G1 phase. Taken together, the data presented here 
reveal that Gpa1 is dynamically regulated. Phosphorylation and ubiquitination are 
independent of the pheromone stimulus and therefore not the result of feedback 
regulation. Rather, these modifications occur in conjunction with the cell cycle. Thus, 
the G protein is simultaneously a regulator of, and regulated by, cell cycle 
progression. 
 
Discussion 
It is now well established that the G protein subunit Gpa1 is ubiquitinated. 
Here we have begun to discern how this ubiquitination event is regulated. Our 
investigation began by showing that Gpa1 is phosphorylated and that 
phosphorylation results in an electrophoretic mobility shift of the protein. This 
property allowed us to determine that a single kinase (Elm1) is necessary for proper 
phosphorylation in vivo. Using purified components, we showed that Elm1 is also 
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sufficient for Gpa1 phosphorylation in vitro. Elm1 is expressed primarily in S and 
G2/M phases of the cell cycle. Correspondingly, we found that the G protein is 
phosphorylated in a cell cycle-dependent manner. Gpa1 is polyubiquitinated by SCF, 
and phosphorylation is typically required for SCF-mediated ubiquitination. Thus we 
investigated whether phosphorylation leads to ubiquitination of Gpa1, and whether 
ubiquitination also occurs in a cell cycle-dependent manner. Indeed, whereas Gpa1 
phosphorylation peaks in G2/M phase, ubiquitination occurs in the subsequent G1 
phase. These findings establish that G proteins can be regulated by progression 
through the cell cycle. More broadly, they raise the possibility that other pathway 
components may also be subject to cell cycle regulation. 
The participation of Elm1 in G protein signaling was unexpected. Elm1 is best 
known as a protein kinase that coordinates events leading to cell division, including 
bud emergence, mitosis and cytokinesis (1, 4, 8, 26, 45, 49). In this capacity, Elm1 
phosphorylates protein kinases involved in septin organization and cytokinesis (Gin4 
and Cla4) (1, 4, 45), another kinase that phosphorylates and de-activates the 
morphogenesis checkpoint protein Swe1 (Hsl1) (8, 49), and a fourth kinase that 
inhibits the mitotic exit network when the spindle position checkpoint is activated 
(Kin4) (6). It is unlikely that Gpa1 is regulated by any of these Elm1 substrates, given 
that deletion of those genes has no effect on Gpa1 phosphorylation or pheromone 
responsiveness. Thus Gpa1 represents a new target of Elm1.  
 Whereas elm1Δ was the only mutant that exhibited a loss of Gpa1 
phosphorylation, some residual phosphorylation could still be detected in vivo  (Fig. 
2.3 A). Therefore, we speculate that Gpa1 is phosphorylated by another kinase. 
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Possibilities include kinases that are absent from the gene deletion array, kinases 
essential for cell viability, and kinases that have functions related to Elm1. Elm1 is 
one of three closely related kinases, including Tos3 and Sak1. All three proteins are 
known to phosphorylate and activate Snf1 (the yeast homolog of human AMPK 
(AMP-activated protein kinase), primarily under conditions of glucose starvation (19). 
Under the normal growth conditions used to assess mating pheromone responses 
however, deletion of TOS3, SAK1, or SNF1 does not appear to affect Gpa1 
phosphorylation or pheromone signaling (Fig 2.2). Taken together, our findings 
indicate that Elm1 is largely responsible for Gpa1 phosphorylation, is uniquely able 
to regulate the pheromone response pathway, and does so in a cell cycle-dependent 
manner. 
Other lines of evidence support the model that Elm1 phosphorylates Gpa1. 
First, Gpa1 is neither phosphorylated nor ubiquitinated when Elm1 is absent. In 
contrast, we did not observe any such differences in the absence of 108 other 
kinases. Second, we did not observe any differences in the absence of 31 different 
protein phosphatases. Thus it is unlikely that Elm1 acts indirectly by inhibiting the 
function of a Gpa1-phosphatase. Third, we detected a substantial accumulation of 
phosphorylated Gpa1 in the absence of the SCF function. Finally, we detected a 
substantial enrichment of Gpa1 polyubiquitination in G1-arrested cells as compared 
with S or G2/M-arrested cell cultures. These data confirm that phosphorylation and 
ubiquitination occur in a cell cycle-dependent manner and that phosphorylation 
precedes ubiquitination. 
As the primary negative regulator of the mating pathway, Gpa1 is a logical 
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target for regulation by posttranslational modifications. We have shown that 
pheromone-dependent gene transcription is diminished in cells that lack Elm1 
function. Similarly, pheromone-dependent gene transcription is diminished in cells 
expressing Gpa1ΔUD. Gpa1ΔUD lacks a domain (UD, residues 129–236) that is 
required for ubiquitination by SCF as well as phosphorylation by Elm1 (5, 32, 57). 
The Gpa1 ubiquitination domain cannot be the only target of phosphorylation, 
however, because mutation of all 15 serine and threonine residues within this region 
failed to diminish phosphorylation in vitro or in vivo (data not shown). Thus, alternate 
phosphorylation sites are likely to exist, and these may likewise target the protein for 
polyubiquitination, at least under some circumstances. Taken together, these data 
indicate that phosphorylation can occur at multiple sites throughout the protein, 
whereas ubiquitination is restricted to a specific subdomain of the protein. 
We have now identified the primary components necessary for Gpa1 
phosphorylation (Elm1) and polyubiquitination (SCF). While much has been learned, 
substantive questions remain. For instance, we have yet to establish how Elm1 and 
SCF work together to modulate G protein function. All existing data indicate 
redundancy within this process because perturbations to phosphorylation or 
ubiquitination have modest effects on G protein stability. Selective pressure in yeast 
may have instilled this property because cells lacking Gpa1 cannot grow as a result 
of G1 cell cycle arrest. Alternatively phosphorylation and ubiquitination may affect G 
protein signaling in other ways. For example, ubiquitination could affect G protein 
catalytic activity. Ubiquitination could also serve to restrict Gpa1 localization to 
specific signal transduction complexes. Considering that Elm1 is localized 
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predominately to the bud neck between dividing cells, Gpa1 phosphorylation and 
subsequent polyubiquitination may occur only during cell division or within a 
specialized subdomain of the plasma membrane (Fig. 2.8). Indeed, Gpa1 was 
recently shown to concentrate to the bud neck during G2/M phase, where Elm1 is 
located (48). 
The yeast mating response is perhaps the best-characterized of any signal 
transduction system, yet it continues to reveal new mechanisms of signal regulation. 
It has long been known that pheromone stimulation activates the G protein and 
promotes cell cycle arrest in G1. We now find that the G protein α subunit is 
phosphorylated and ubiquitinated in a manner that is contingent on cell cycle 
progression. The abundance of phosphorylated Gpa1 increases as cells progress 
through the S and G2/M phases and decreases rapidly after cells divide and enter G1 
phase. Taken together, these data show that the G protein can be dynamically 
regulated. More broadly, these findings reveal a previously unsuspected degree of 
coordination between G protein signaling and cell division. 
 
Experimental Procedures 
Strains and Plasmids – Standard methods for growth, maintenance, and 
transformation of yeast and bacteria were used throughout. To ensure accurate cell 
density comparisons, a diluted fraction of each cell culture was lightly sonicated 
before measurement at an A600 nm to break apart cell clusters that commonly form 
between elm1Δ cells. Strains used in this study were BY4741 (MATa leu2Δ met15Δ 
his3Δ ura3Δ), elm1Δ (BY4741 elm1Δ::KanMX4), ELM1-TAP (Yeast TAP-fusion 
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library, Open Biosystems), cdc6-1 (BY4741 cdc6-1 hph) (provided by Jean Cook, 
University of North Carolina), 15Dau (MATa ade1 his2 leu2–3, trp1–112, ura3Δ), 
cdc28-1 (15Dau, cdc28-1) (provided by Beverly Errede, University of North 
Carolina), LHY488 (MATa his3-Δ200 leu2Δ1 ura3–52 lys2–801 trp1Δ63 ade2–101), 
LHY489 (LHY488 cim3-1) (provided by Linda Hicke, Northwestern University) (17), 
MTY235 (MATa ade2-1 his3–11,15 leu2–3,112 trp1-1 ura3-1 can1–100), MTY670 
(MTY235 cdc34-2), and MTY668 (MTY235 cdc4-1) (provided by Mike Tyers, Samuel 
Lunenfield Research Institute) (50). Integrated yeast strains were constructed by 
plasmid integration of pRS406-GPA1-(81-1539 bp) or pRS406-GPA1-(81-1539 
bp)S200A at the naturally occurring HindIII site within GPA1, resulting in a single full-
length copy of GPA1 at its endogenous locus. Integration was validated by 
immunoblotting with wild-type cells to confirm loss of the phosphorylation dependent 
mobility shift (in the case of S200A). All experiments were done in BY4741 unless 
otherwise specified. 
Plasmid Construction – All yeast plasmids used can be found in Table 2.1. 
Yeast shuttle plasmids pRS315-ELM1 and pRS316-ELM1 were constructed by PCR 
amplification of ELM1 ± 500 bp flanking the open reading frame (primers SalI-ELM1-
F and SacI-ELM1-R) and directional cloning into the SalI and SacI sites of pRS315 
or pRS316. Single point mutations (Gpa1S200A, Gpa1S200E, and Elm1K117R) were 
constructed by QuikChange (Stratagene) mutagenesis using the indicated primers 
(Table 2.2). Plasmids containing gpa115S/T-A were constructed by chemical synthesis 
of a 413-bp fragment of GPA1 (base pairs 392-786 of the open reading frame 
starting from the naturally occurring HindIII restriction site of GPA1) within which all 
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serine and threonine codons were mutated to alanine, and a silent BglII site was 
introduced by mutation of base pairs 781 and 783 (GenScript). The synthesized 
fragment was cloned into GPA1 plasmids in which the same silent BglII mutation 
was introduced by QuikChange (using primer GPA1-BglII-F/R), followed by 
restriction digestion with HindIII and BglII. pYEX 4T-1-GST-ELM1 was purified from 
the yeast GST-fusion library host strain EJ 758 (33) using a yeast plasmid miniprep 
kit (Zymo Research) and then retransformed into BY4741 elm1Δ cells for expression 
of GST-Elm1. All plasmids were verified by DNA sequencing. 
Growth Arrest Conditions and Release – Log-phase cell cultures were 
arrested in G1 phase with a synthetic α-factor peptide (30 µM final concentration, 
CHI Scientific 53424), in S phase by addition of hydroxyurea (added in powder form 
to 10 mg/ml final concentration, Sigma Aldrich H8627), and in G2/M phase by 
addition of nocodazole (15 µg/ml final concentration, SigmaAldrich M1404). Note 
that for G2/M phase arrest, cells were first treated with 1% dimethyl sulfoxide for 30 
min at 30 °C, followed by addition of nocodazole (100x stock at 1.5 mg/ml in 
dimethyl sulfoxide), resulting in a 2% final concentration of dimethyl sulfoxide in the 
cell culture. Each arrest was allowed to proceed for 2.5 h at 30 °C unless otherwise 
noted. Cells were released from arrest by centrifugation and washing with 3 x 100 ml 
of sterile water followed by resuspension in fresh medium to an A600 nm  of 0.7 and 
growth at 30 °C. 
Growth of Temperature-sensitive Mutants -Temperature sensitive mutants 
(cdc6-1, cdc28-1, cdc4-1, or cdc34-2) and the isogenic wild type counterstrains were 
grown at a permissive temperature (25 °C) to early log-phase and then shifted to the 
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restrictive temperature (37 °C) for 2.5 h to induce cell cycle arrest in G1 phase 
(cdc28-1 cells), or early S phase (cdc6-1 cells) and for 1 h to inactivate the SCF 
ubiquitin ligase (cdc4-1 or cdc34-2 cells). 
In Vivo Ubiquitination Assays – Gpa1 polyubiquitination was detected by 
constitutive (ADH1 promoter) expression of Gpa1 in yeast harboring a temperature-
sensitive mutation (cim3-1) or by coexpression of Gpa1 and Myc-ubiquitin as 
described previously (57). For cim3-1 and isogenic wild-type cells, log-phase 
cultures were grown at the permissive temperature (25 °C) to an A600 nm of 0.5-0.6, 
followed by transition to the restrictive temperature (37 °C) for 3 h. Inducible Myc-
ubiquitin strains were grown at 30 °C to an A600 nm of 0.5-0.6, followed by addition of 
CuSO4 to 100 µM for 3 h at 30 °C as described previously (40). Detection of Gpa1 
ubiquitination at different cell cycle stages was accomplished by arresting log-phase 
cells followed by induction of Myc-ubiquitin expression for 3 h. 
Protein Detection-Unless otherwise noted, cell pellets were harvested by 
addition of 100% trichloroacetic acid (5% final concentration), centrifugation at 4000 
xg for 1 min, washing with 1ml of 10mM NaN3, and then stored as a frozen cell pellet 
at -80 °C. Protein extracts were generated by glass bead lysis in trichloroacetic acid 
as described previously (27) and resolved by 10% SDS-PAGE and immunoblotting. 
Membranes were probed with anti-Gpa1 at 1:1000 (12), anti-FLAG at 1:1000 
(F1804, Sigma Aldrich), anti-Clb2 at 1:350 (sc-9071, Santa Cruz Biotechnology), 
anti-p44/42 at 1:500 (9101L, Cell Signaling Technology), anti-Kss1 at 1:350 (sc-
6775, Santa Cruz Biotechnology), anti-Fus3 at 1:350 (sc-6773, Santa Cruz 
Biotechnology), anti-G6PDH at 1:50,000 (A9521, Sigma Aldrich), anti-Myc at 1:100 
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(9E10 mouse monoclonal antibody), and anti-protein A at 1:50,000 (P3775, Sigma 
Aldrich). Immunoreactive species were visualized by chemiluminescent detection 
(PerkinElmer Life Sciences) of horseradish peroxidase-conjugated anti-rabbit (170-
5046) or anti-mouse IgG (170-5047) (Bio-Rad). Where indicated, image 
densitometry was conducted using National Institutes of Health ImageJ software. 
Statistical analysis was conducted using GraphPad Prism 4 for a minimum of three 
independent experiments unless noted otherwise. 
Phosphatase Assays- Cells grown to an A600 nm of 1.0 were harvested by 
centrifugation at 2000 xg and stored at -80 °C. Cell pellets were resuspended in 1x λ 
phosphatase buffer (New England Biolabs) containing 50 mM HEPES (pH 7.5), 100 
mM NaCl, 2 mM DTT, 0.01% Brij 35, 1 mM MnCl2, and 1x EDTA-free protease 
inhibitors (Roche). Each resuspended pellet was split in half and subjected to glass 
bead lysis in the presence or absence of phosphatase inhibitors (50 mM NaF and 
1.3 mM sodium orthovanadate) (S6508, Sigma Aldrich). Lysates were centrifuged at 
21,000 xg for 15 min, and the supernatant fraction was then collected into a fresh 
tube with or without 60 units (2.25 units/µl final concentration) of λ protein 
phosphatase (New England Biolabs) for 30 min at 30 °C. The reaction was stopped 
by addition of 6x SDS-PAGE loading buffer, and the samples were immediately 
subjected to SDS-PAGE and immunoblot analysis. Alternatively, phosphatase 
assays were conducted on purified protein. Briefly, 1 µl of yeast-purified Gpa1-FLAG 
was diluted in 1x λ-phosphatase buffer with or without 20 units (2 units/µl final 
concentration) λ protein phosphatase. 
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GST-Elm1 Expression, Purification and in Vitro Kinase Assay – 1 liter 
cultures of elm1Δ cells harboring pYEX-4T1-GST-ELM1 or elm1K177R were grown to 
A600 nm of 0.7 and treated with 500 µM CuSO4 for 2 h to induce expression of GST-
Elm1. Cells were harvested, washed with water, and stored at −80 °C. All 
procedures were conducted at 4 °C unless noted otherwise. The cell pellets were 
lysed by glass bead agitation in lysis buffer containing 20 mM Tris-HCl (pH 8.0), 400 
mM NaCl, 2 mM MgCl2, 5% glycerol, 0.1% Triton X-100 (Sigma-Aldrich), 1 mM DTT, 
1× protease inhibitor mixture tablets (Roche), and 500 µM PMSF. The lysate mixture 
was subjected to microcentrifugation at 21,000 xg for 10 min, and GST-Elm1 was 
purified from the soluble extract using glutathione-Sepharose™ 4 Fast-flow (GE 
Healthcare) followed by washing in buffer containing 20 mM Tris-HCl (pH 8.0), 400 
mM NaCl, 2 mM MgCl2, 5% glycerol, 1 mM DTT and elution with dialysis buffer 
containing 20 mM glutathione (pH 7.5). Eluted protein was dialyzed with a slide-a-
lyzer mini cartridge (Pierce) into kinase storage buffer containing 20 mM Tris-HCl 
(pH 8.0), 100 mM NaCl, 2 mM MgCl2, and 5% glycerol. In vitro kinase assays were 
conducted by incubating 0.08-0.16 pmol of purified GST-Elm1 (3.2-6.4 nM final 
concentration) and 12.5-25 pmol of recombinant purified Gpa1 (0.5-1 µM final 
concentration) in 1× kinase reaction buffer previously described for in vitro Elm1 
kinase assays and containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM DTT, 2 
mM EGTA, 200 mM sodium orthovanadate, and 10 µCi of [γ-32P]ATP (PerkinElmer 
Life Sciences) for 1 h at 30 °C (53). Reactions were stopped by addition of 6× SDS-
PAGE loading buffer and immediately subjected to SDS-PAGE.  The resulting gel 
was dehydrated and exposed to autoradiography film (HyBlot CL, Denville 
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Scientific). 
Affinity Purification of Gpa1-FLAG - Yeast harboring pRS316-ADH-GPA1-
FLAG was grown to early log-phase and then harvested by centrifugation. The 
resulting cell pellet was lysed, and Gpa1-FLAG was purified as described previously 
(5). 
Gene Transcription Assay - Pheromone-dependent transcription reporter 
assays were conducted as described previously (24). Briefly, cell cultures at an A600 
nm of 0.8 were dispensed (90 µl into each of 48 wells of a 96-well plate) and mixed 
with 10 µl of α-factor peptide at the indicated concentration for 90 min at 30 °C. Next, 
each well was mixed with 20 µl of FDG solution (130 mM PIPES (pH 7.2), 0.25% 
Triton-X100, 0.5 mM fluorescein di-β-galactopyranoside (Marker Gene 
Technologies, M0250)) for 1 h at 37 °C. The reaction was stopped by the addition of 
20 µl of 1 M sodium bicarbonate followed by fluorescence quantification using a 
fluorescence plate reader (SpectraMax M5, Molecular Devices). 
Escherichia coli Expression of His6 Fusion Proteins – Recombinant His6-
Gpa1 was expressed by autoinduction as described previously (47). All procedures 
were conducted at 4 °C unless noted otherwise. Briefly, competent BL21-RIPL cells 
(Stratagene) were transformed with the indicated expression vector. 5 ml of 
saturated starter cultures (containing ZY medium (10 g/l tryptone, 5 g/l yeast extract) 
with 15 mg of glucose, 50 µg/ml carbenicillin) were used to inoculate 800 ml of ZY 
medium containing 1×M solution (25 mM Na2HPO4, 25 mM KH2PO4, 50 mM NH4Cl, 
5 mM Na2SO4), 1×5052 solution (0.5% (w/v) glycerol, 0.5% (w/v) glucose, 10% (w/v) 
α-lactose), 50 mM MgSO4, and 50 µg/ml carbenicillin. Cultures were grown for 8 h at 
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37 °C and then shifted to 18 °C overnight.  The G protein was purified using nickel-
affinity chromatography as described previously (54) but without cleavage of the N-
terminal His6 tag. The resultant protein was dialyzed by a slide-a-lyzer (Pierce) in 20 
mM Tris-HCl (pH 8.0), 100 mM NaCl, 2 mM MgCl2, 20 µM GDP, and 0.5 mM tris(2-
carboxyethyl)phosphine. 
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Table 2.1: Table of plasmids used in this study 
 
Name Description Source 
pAD4M  2 µm AmpR LEU2 ADH1 promoter/terminator (2) 
pAD4M-GPA1 2 µm AmpR LEU2 ADH1 GPA1 (11) 
pAD4M-GPA1S200A 2 µm AmpR LEU2 ADH1 GPA1S200A (54) 
pAD4M-GPA1S200E 2 µm AmpR LEU2 ADH1 GPA1S200E (54) 
pAD4M-GPA115S/T-A 2 µm AmpR LEU2 ADH1 GPA115S/T-A This Study 
pRS406-GPA181-1539 int AmpR URA3 GPA181-1539 (no promoter)  (5) 
pRS406-GPA181-1539, S200A int AmpR URA3 GPA181-1539, S200A This Study 
pRS316-ADH1-GPA1-FLAG  CEN6 AmpR URA3 ADH1 GPA1-FLAGInternal  (5) 
pRS315 CEN6 AmpR LEU2  (41) 
pRS316 CEN6 AmpR URA3 (41) 
pRS315-ELM1  CEN6 AmpR LEU2 ELM1 +/- 500bp  This Study 
pRS315-ELM1K117R  CEN6 AmpR LEU2 ELM1K117R +/- 500bp  This Study 
pRS316-ELM1 CEN6 AmpR URA3 ELM1 +/- 500bp  This Study 
pRS316-ELM1K117R CEN6 AmpR URA3 ELM1K117R +/- 500bp This Study 
pRS423-FUS1-LacZ 2 µm AmpR HIS3 FUS1-lacZ  (23) 
pYEX 4T-1-GST-ELM1 2 µm AmpR URA3 leu2-d GST-CUP1-ELM1 (33) 
pYEX 4T-1-GST-ELM1K117R 2 µm AmpR URA3 leu2-d GST-CUP1-ELM1K117R  This Study 
pLIC-6HIS-GPA1  AmpR 6HIS-TEV-GPA1 (54) 
pLIC-6HIS-GPA1S200A AmpR 6HIS-TEV-GPA1S200A  This Study 
6HIS-TEV-GPA1ΔN AmpR 6HIS-TEV-GPA1Δ1-36  This Study 
pLIC-6HIS-GPA1ΔUD  AmpR 6HIS-TEV-GPA1Δ1-36, 129-236  This Study 
pND747 2 µm AmpR URA3 CUP1-MYC-Ubiquitin  (40) 
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Table 2.2: Oligonucleotide primer sequences 
 
Name Sequence 5'-3' 
SalI-ELM1-F TTTTGTCGACGTCAATTGCCGCACCATTAATAC 
SacI-ELM1-R TTTTGAGCTCGAATCACTTTGAATAGCAGAACTAACC 
GPA1-S200A-F* CTGATAGAAACAACAGTGCTAGAATTAACCTACAGG 
GPA1-S200E-F* CTGATAGAAACAACAGTGAGAGAATTAACCTACAGG 
GPA1-Bgl2-F* GTATAAAGCAGTGTTTTGCAAGATCTAATGAGTTTCAATTGGA 
ELM1-K117R-F* CAAGGTTGTTGCTGTCAGGATTATACCAAAAAAACC 
 
*Only forward sequence shown for QuikChange primers. Mutations indicated with 
bold typeface. 
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CHAPTER III 
 
REGULATION OF G PROTEIN SIGNALING BY SNF1/AMPK KINASES*Φ 
 
Extracellular signals such as nutrients and hormones cue intracellular 
pathways to produce adaptive responses. Often, there are multiple input signals and 
cells must coordinate these signals to produce an appropriate outcome. Here we 
show that components of a glucose-sensing pathway act on components of a G 
protein-mediated pathway in yeast Saccharomyces cerevisiae. We demonstrate that 
the G protein α subunit Gpa1 is phosphorylated in response to low glucose 
conditions, and that this phosphorylation contributes to a reduction in pheromone-
dependent MAPK activation, gene transcription, cell morphogenesis and mating 
efficiency. The Snf1/AMP-activated protein kinase (AMPK) kinases, Elm1, Sak1, and 
Tos3 phosphorylate Gpa1 and contribute to diminished mating. Conversely, the Snf1 
phosphatase Reg1 is needed to reverse phosphorylation of Gpa1 and to restore the 
mating response. Thus the same kinases and phosphatase that regulate AMPK/Snf1 
also regulate Gpa1. More broadly, these results indicate that the glucose-sensing 
and mating response pathways communicate directly to coordinate cell behaviors. 
                                            
* Elements of the work referenced in this chapter have been submitted for publication: Clement ST, 
Dixit G, and Dohlman HG. (2013). Regulation of G protein signaling by Snf1/AMPK kinases.  
 
Φ Figures 3.1, 3.2, 3.3, 3.4, 3.5, 3.6A, 3.7 contributed by Sarah T. Clement. Figures 3.6B, 3.6C 
contributed by Gauri Dixit 
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Introduction  
Hormones, neurotransmitters, odors, and environmental signals are 
commonly detected by G protein coupled receptors (GPCRs). Upon ligand binding, 
the activated receptor causes the G protein α subunit to release GDP, bind GTP, 
and dissociate from the G protein βγ subunits, thereby initiating an appropriate 
cellular response. For instance, the peptide hormone glucagon is produced in 
response to a reduction in blood glucose and activates a GPCR-activated pathway, 
triggering the breakdown of cellular glycogen and release of glucose into the 
circulation (33). Whereas the ability of specific GPCRs to control glucose metabolism 
is well established, less is known about how changes in glucose availability affect 
GPCR signaling.  
G protein signaling cascades are highly conserved in animals, plants, and 
fungi. In the yeast Saccharomyces cerevisiae, peptide pheromones trigger a series 
of signaling events leading to the fusion of haploid a and α cell types. In mating type 
a cells, α-factor pheromone binds to the GPCR Ste2, which is coupled to a 
heterotrimeric G protein composed of Gpa1 (Gα), Ste4 and Ste18 (Gβγ). The free 
Gβγ dimer then activates a protein kinase cascade that culminates with the MAP 
kinase Fus3 as well as the related MAPK Kss1. Mating pathway activation leads 
ultimately to new gene transcription, G1 cell cycle arrest, and morphological 
changes to form an a/α diploid cell (9). 
In addition to activation by receptors, G proteins are regulated by post-
translational modifications, which are often dynamic and contribute directly to signal 
transmission. For instance, Gpa1 is modified by myristoylation, palmitoylation, 
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ubiquitination, and phosphorylation (4, 37, 42, 45). In an earlier effort to identify the 
Gpa1 kinase, we screened 109 gene deletion mutants, representing most of the 
non-essential protein kinases in yeast. By this approach we identified a single kinase 
Elm1 that phosphorylates Gpa1. In nutrient rich conditions, Elm1 is expressed 
predominantly during G2/M phase and this pattern leads to concomitant, cell-cycle 
dependent phosphorylation of Gpa1. 
 In addition to Gpa1, Elm1 phosphorylates and regulates a number of proteins 
necessary for proper cell morphogenesis and mitosis (39). Elm1 is also one of the 
three kinases that phosphorylates and activates Snf1 (44), the founding member of 
the AMP-activated protein kinase (AMPK) family (5). Under conditions of glucose 
limitation, Snf1 is phosphorylated on threonine 210 (25). Once activated, Snf1 
promotes the transcription of metabolic genes to maintain energy homeostasis (12, 
14, 52). Here we demonstrate that Gpa1 is likewise phosphorylated in response to 
glucose limitation. Moreover, Gpa1 is phosphorylated and dephosphorylated by the 
same enzymes that act on Snf1. Under conditions that promote Gpa1 
phosphorylation, cells exhibit a diminished pheromone response, a delay in mating 
morphogenesis, and a reduction in mating efficiency. These findings reveal a new 
and direct link between the nutrient-sensing AMPK and G protein signaling 
pathways. More broadly they reveal how metabolic and GPCR signaling pathways 
coordinate their actions in response to competing stimuli. 
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Results 
Gpa1 is phosphorylated in response to glucose limitation – We have 
shown previously that Elm1 phosphorylates Gpa1, and that phosphorylation is 
regulated in a cell-cycle dependent manner (45). Elm1 also phosphorylates Snf1, 
among other substrates, but in this case phosphorylation occurs in response to 
glucose limitation. Thus we considered whether glucose availability affects the 
phosphorylation of Gpa1. Since phosphorylation triggers a mobility shift that can be 
detected by immunoblotting with Gpa1 antibodies, we used this technique to monitor 
Gpa1 phosphorylation in 2% and 0.05% glucose media. We found that Gpa1 is 
indeed phosphorylated (Fig. 3.1 A), and that phosphorylation is rapid and sustained 
during low glucose conditions (Fig. 3.1 B). Surprisingly however, Gpa1 was still 
phosphorylated in elm1Δ cells. Since two other proteins, Sak1 and Tos3, are also 
capable of phosphorylating Snf1 (19, 44), we examined whether these kinases, 
alone or in combination, contributed to the phosphorylation of Gpa1 during glucose 
limitation. Of the single kinase deletion mutants, sak1Δ caused the greatest 
decrease in Gpa1 phosphorylation (Fig. 3.1 C). Deletion of all three kinases was 
needed to eliminate phosphorylation entirely (Fig. 3.1 B and D). These results mirror 
those reported previously for Snf1 (15, 19, 44, 49). Snf1 itself does not appear to 
phosphorylate Gpa1, given that the mobility shift was still visible in the snf1Δ mutant 
(Fig. 3.1 E). These results suggest that Gpa1 is a substrate for the Snf1-kinases 
Elm1, Sak1, and Tos3. 
 Having shown that the Snf1-kinases are necessary to phosphorylate Gpa1, 
we asked whether the Snf1-phosphatase, comprised of Glc7 and Reg1 (23), is 
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needed to dephosphorylate Gpa1. Reg1 acts as a regulatory subunit, whereby it 
recruits substrates to the catalytic subunit Glc7 (47). Since the Glc7 gene is 
essential, we tested a reg1Δ mutant. Indeed we found that Gpa1 is more heavily 
phosphorylated in reg1Δ than in wild-type cells, and remains phosphorylated even in 
abundant glucose conditions (Fig. 3.1 A and B). Taken together, these data indicate 
that the kinases and phosphatase that act on Snf1 are likely to act on Gpa1 as well. 
 Snf1 exists as part of a heterotrimeric complex, and phosphorylation is 
partially dependent on the presence of its β subunit (30). Accordingly, we 
investigated whether Gpa1 phosphorylation requires any of its known binding 
partners (2, 7, 36). To that end we monitored Gpa1 phosphorylation in strains 
lacking the G protein coupled receptor (Ste2), the Gβ subunit (Ste4), the GTPase-
activating protein (Sst2), and the atypical Gβ subunit (and phosphatidylinositol 3-
kinase regulatory subunit, Vps15). We found that Gpa1 was still phosphorylated in 
the absence of each binding partner, although phosphorylation was diminished in 
the absence of Ste4 (Fig. 3.1 F). These results suggest that phosphorylation of 
Gpa1, as with Snf1, occurs most efficiently when it is in the heterotrimeric state. 
Having shown that Sak1 is especially important for Gpa1 phosphorylation, we 
investigated whether Sak1 acts on Gpa1. We determined that Sak1 will copurify with 
Gpa1 from cells grown in either 2% or 0.05% glucose conditions (Fig. 3.2 A), 
suggesting that the interaction is not glucose-dependent. To assess if Sak1 is 
sufficient for Gpa1 phosphorylation, we conducted in vitro kinase assays. We found 
that purified Sak1-TAP can phosphorylate purified recombinant Gpa1 (Fig. 3.2 B), 
while the catalytically impaired Sak1D277A mutant could not. Additionally, we 
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examined whether Tos3 can phosphorylate Gpa1. Although we were able to purify 
Tos3 and show modest Gpa1 phosphorylation by in vitro kinase assays (Fig. 3.2 C), 
we were unable to detect an association of Tos3 and Gpa1 in cell lysates. We 
conclude that Sak1 phosphorylates Gpa1.  
Gpa1 is heavily phosphorylated in a reg1Δ mutant even when maintained in 
abundant glucose (Fig. 3.1 A and B). We confirmed that Reg1 can copurify with 
Gpa1, from cells grown in 2% or 0.05% glucose (Fig. 3.2 D). However we were 
unable to purify Reg1 and Glc7 in quantities needed for an in vitro phosphatase 
assay. As an alternative, we purified recombinant Gpa1 and Reg1 and resolved the 
proteins by steric-exclusion chromatography. Gpa1 eluted in two distinct peaks, one 
representing monomeric Gpa1 and a second peak representing Gpa1 in complex 
with Reg1 (Fig. 3.2 E). These results demonstrate a direct and stable association of 
Gpa1 and Reg1. Taken together, these results support the model that Reg1/Glc7 
functions as a Gpa1 phosphatase. 
Elm1, Sak1, and Tos3 dampen mating responses while Reg1 promotes 
mating responses – Mating pheromone α-factor is known to stimulate a kinase 
cascade consisting of Ste11, Ste7, and the MAPK Fus3. To determine if 
phosphorylation of Gpa1 alters its ability to transmit the pheromone signal, we 
monitored Fus3 by immunoblotting with an antibody that recognizes the dually-
phosphorylated, fully active form of the kinase (P-Fus3) (31). The pheromone-
dependent activation of Fus3 was more rapid in elm1Δsak1Δtos3Δ cells compared 
to wild-type cells (Fig. 3.3 A). Pheromone also induces the expression of FUS3 (28) 
but we observed no difference in Fus3 abundance in this case. Thus Elm1, Tos3, 
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and Sak1 are important for suppressing early activation of the mating-specific MAPK 
in response to pheromone.   
Activation of Fus3 results in selective induction of genes needed for proper 
cell fusion (28). To further assess the contribution of Elm1, Sak1, and Tos3, we 
measured pathway-specific transcription using a reporter comprised of the FUS1 
promoter fused to the β-galactosidase gene. Compared to wild-type cells, 
elm1Δsak1Δtos3Δ cells had a ~2-fold increase in maximal pheromone-induced gene 
transcription (Fig. 3.3 B), and an even greater relative increase under basal 
conditions.  
As a counterpart to the Snf1-kinases, we examined the role of the Glc7/Reg1 
phosphatase in the mating response. Once again, we used a reg1Δ mutant strain as 
well as a Glc7-binding deficient mutant, Reg1F468R (32). Whereas activation of Fus3 
reached maximal activation after about 30 minutes in wild-type cells, peak activation 
was delayed to 60 min in the reg1Δ mutant cells (Fig. 3.3 C). The reg1Δ mutant also 
exhibited a 40% decrease in pheromone-induced transcription (Fig. 3.3 D). Proper 
signaling was restored upon plasmid-borne expression of wild-type Reg1 but not 
Glc7-binding mutant Reg1F468R (Fig. 3.3 D).  
Since elm1Δsak1Δtos3Δ cells lack proper Snf1 activation, we examined the 
response of snf1Δ cells to pheromone. Whereas the elm1Δsak1Δtos3Δ strain 
exhibits an elevated response to pheromone, the snf1Δ mutant produces a 
dampened response in both lower MAPK activation and lowered transcriptional 
output (data not shown). Thus the effects of glucose and the Reg1-Elm1/Sak1/Tos3 
system do not simply reflect regulation of the well-known target Snf1. Taken 
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together, these data reveal that Elm1, Sak1, and Tos3 act to negatively regulate the 
mating pathway. In contrast, Reg1 serves as a positive regulator of the pathway. 
Glucose limitation dampens mating pathway response – The data 
presented above reveal that Gpa1 is dynamically modified by phosphorylation, is 
phosphorylated in low glucose conditions, and that the kinases and phosphatase 
acting on Gpa1 are the same as those acting on Snf1. The Snf1 kinase complex and 
its human counterparts, the AMP-activated kinases, serve as molecular switches to 
turn on catabolic pathways while suppressing anabolic pathways in energy-poor or 
other stress conditions (13). In light of these findings, we postulated that Gpa1 
serves as a point of crosstalk to delay mating during periods of glucose limitation. To 
test this model, we investigated how a decrease in extracellular glucose alters 
MAPK activation and mating-specific transcription, as well as the consequent 
changes in cell morphology and mating efficiency. 
We first monitored Fus3 activation and observed a dampened response to 
pheromone when glucose is limiting (Fig. 3.4 A). We then conducted the same 
experiment in cells lacking Elm1, Sak1, and Tos3; under these conditions, there was 
no effect of limiting glucose on P-Fus3 (Fig. 3.4 B). We also examined cells lacking 
Reg1 and observed a dramatic decrease in P-Fus3 during glucose limitation, 
particularly in later time points (Fig. 3.4 C). Changes in MAPK activation were 
mirrored in the transcriptional reporter assay, with the exception of the reg1Δ mutant 
in low glucose (Fig. 3.5 A). This difference suggests that Reg1 influences events 
both upstream and downstream of the MAPK. Taken together, these data suggest 
that the Snf1-kinases serve to down-regulate the mating pathway.  
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 To assess if other components of the mating pathway are affected by low 
glucose, we activated the pathway downstream of Gpa1 using a constitutively active 
MAPKKK mutant (STE11-4) (40). Wild-type cells expressing STE11-4 trigger MAPK 
phosphorylation even in the absence of pheromone, but in this case activity was 
elevated by the low glucose conditions (Fig. 3.5 B). Given that signal amplification is 
seen upon stimulation with STE11-4 but not with pheromone, we infer that there is a 
competing signal amplification event downstream of Ste11, but it is kept in check by 
events upstream of Ste11. In the longer term the pheromone response, including 
mating (see below), is suppressed under low glucose conditions.  
Fus3 activity is a function of gene induction as well as protein 
phosphorylation, meaning there is a kinase-dependent positive feedback loop that 
controls its own expression. While the STE11-4 epistasis experiments reveal that the 
G protein serves to dampen Fus3 phosphorylation in early signaling events, we 
postulate that the total activity of Fus3 is influenced by its expression in the long 
term. Indeed we observed dampened Fus3 induction in low glucose conditions in 
both reg1Δ and wild-type strains (Fig. 3.4 A and C). Persistent suppression of Fus3 
expression could account for the fact that, of all the strains tested, this mutant shows 
the greatest glucose-dependent change in Fus3 phosphorylation (Fig. 3.4 C) but the 
smallest glucose-dependent change in Gpa1 phosphorylation (Fig. 3.1 A). 
Ultimately, a stress-dependent reduction of pheromone responses should 
lead to impaired mating. It has long been known that mating in yeast is most efficient 
when glucose is abundant (34), although these effects were never quantified or 
characterized by microscopy. In our analysis we observed a ~3-fold reduction in 
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mating in 0.05% glucose compared to 2% glucose conditions (Fig. 3.6 A). We then 
tracked pheromone-induced morphological changes, including polarized cell 
expansion (shmoo) producing the eventual site of haploid cell fusion (50). The use of 
a microfluidic device allowed us to maintain fixed concentrations of glucose and 
pheromone over time. In 2% glucose media, the addition of α-factor pheromone 
resulted in shmoo formation at approximately 120 minutes. In 0.05% glucose media, 
the addition of α-factor pheromone resulted in shmoo formation after 180 minutes 
(Fig. 3.6 B). Moreover, whereas pheromone-treated cells normally arrest in the first 
G1 phase, cells in 0.05% glucose divided once and did not arrest until the second 
G1 phase. We observed no differences in the rate of cell division (budding) when 
pheromone was absent (Fig. 3.6 C). These observations indicate that general 
metabolic and cellular functions are not substantially degraded in low glucose, at 
least for the first four hours. We conclude that pathway suppression and delayed 
morphogenesis are sufficient to reduce mating efficiency when glucose is limiting. 
More broadly, the same processes that control the metabolic regulator AMPK/Snf1 
also limit the pheromone signaling pathway.  
 
Discussion 
 Whereas the core components of the G protein and glucose-sensing 
pathways have been known for decades, the connections between these two 
pathways had not been investigated previously. Here we show that a G protein is 
phosphorylated during glucose limitation, in the manner of Snf1. Moreover, the 
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phosphatase and kinase components shown previously to act on Snf1 also target 
Gpa1. When Gpa1 is phosphorylated, pheromone responses are abrogated. 
 While much has been learned, important questions remain. For example, the 
sites of Gpa1 phosphorylation have not been mapped completely, and it is not clear 
how phosphorylation and dephosphorylation are regulated depending on growth 
conditions and cell cycle stage. Current evidence indicates that Snf1 kinases are 
always active (29), but the activity of the Glc7/Reg1 phosphatase is likely glucose-
regulated (6, 26, 30). In addition, the Snf1 kinase complex undergoes a 
conformational change in low energy environments by the binding of ADP to the 
regulatory subunit, Snf4 (24). Consequently, Snf1 is no longer dephosphorylated 
and persists in an activated phosphorylated state until glucose and ATP levels are 
restored. By analogy with Snf1, it is possible that Gpa1 is constitutively 
phosphorylated but fails to become dephosphorylated in low glucose conditions. 
Gpa1 does not bind to adenosine nucleotides however; so another ligand may 
dictate conformation. So far we have determined that Gpa1 phosphorylation is 
unaffected by a mutation that prevents hydrolysis of GTP to GDP (Fig. 3.7 A). Thus 
another glucose-mediated change may alter the conformation of the G protein, the 
phosphatase, or the protein kinases. For instance, cytoplasmic pH drops rapidly in 
response to low glucose, in part mediated by the dampened activity of the H+-
ATPase Pma1 (51). Changes in pH could produce, either directly or indirectly, 
conformational changes in Gpa1 leading to increased phosphorylation. Aside from 
Pma1, candidate regulators include the glucose sensor proteins Snf3 and Rgt2 (27) 
as well as a glucose sensing GPCR Gpr1 (21). We determined that Rgt2 and Snf3, 
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but not Gpr1, are required for Gpa1 phosphorylation in low glucose conditions (Fig. 
3.7 B). Rgt2 and Snf3 regulate hexose transporter genes, thereby controlling 
intracellular glucose availability (27). In the absence of Rgt2 and Snf3, cells do not 
respond properly to changes in extracellular glucose. Consequently Gpa1 and Snf1 
are phosphorylated even when glucose is abundant (Fig. 3.7 B). Additional work will 
be needed to determine how these glucose sensors transmit a signal to Gpa1. 
Finally we are interested to know whether other pathway components are also 
regulated by the AMPK pathway. 
Yeast has long served as a model for investigating fundamental mechanisms 
of cell signaling and regulation. Our analysis has revealed, for the first time, glucose-
dependent regulation of a G protein α subunit and a G protein-mediated signaling 
pathway. Analysis of both pathways is critical for understanding human health and 
disease as they are implicated in numerous physiological responses and are 
important targets of pharmaceuticals, including metformin for type 2 diabetes and 
adrenergic antagonists for hypertension (48, 53). Dynamic phosphorylation of a G 
protein α subunit, in response to diminished glucose availability, represents a striking 
example of crosstalk between two critically important signaling systems. More 
broadly, these findings demonstrate a degree of coordination that serves to prioritize 
signaling events during cellular stress. Given the conservation of G protein and 
AMPK signaling across species, the findings described here may reveal similar 
mechanisms of signal coordination in humans. 
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Experimental Procedures 
 Strains, Plasmids and Growth of Cultures. Standard methods for growth, 
maintenance, and transformation of yeast and bacteria were used throughout. 
Strains used in this study were BY4741 (MATa leu2Δ met15Δ his3Δ ura3Δ) and 
BY4741-derived mutants constructed by use of the KanMX4 G418-resistance 
marker (Yeast Deletion Clones, Invitrogen; originally purchased from Research 
Genetics). The snf1Δ (BY4741 snf1Δ::KanMX4) strain from Research Genetics did 
not produce a consistent phenotype so the strain was remade by PCR amplification 
of the KanMX4 cassette and transformation of the parent strain (20). Double gene 
deletion and triple gene deletion strains were made using PCR-mediated gene 
disruption cassettes from pRS400 series vectors (3). Table of strains, plasmids, 
primers used in this study can be found in Tables 1, 2, and 3. Cells were grown in 
yeast extract peptone medium (YPD) or synthetic complete medium (SCD) 
containing 2% (w/v) D-glucose. Low glucose treatment was conducted by growth in 
2% glucose media to early-log phase, then cells were centrifuged and washed with 
0.05% glucose media before being resuspended in 0.05% glucose media for 5 min. 
Cells were then collected for immunoblotting or further treated with α-factor 
pheromone. 
Plasmid Construction. Plasmid pRS313-SAK1 was constructed by PCR 
amplification of SAK1 ± 500 bp flanking the opening reading frame (primers SacII-
SAK1-F and SmaI-SAK1-R) and directional cloning into the SacII and SmaI sites of 
pRS313. pRS316-REG1 was constructed using the above method using primers 
XhoI-REG1-F and KpnI-REG1-R and cloning into pRS316. Single point mutation of 
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Reg1F468R was constructed by QuikChange (Stratagene) mutagenesis using primer 
REG1-F468R-F and its complement. pAD4M-GPA1-FLAG was constructed by 
amplifying the GPA1-FLAGInternal ORF from pRS316-ADH-GPA1-FLAG (4) using 
SmaI-ADH1-F and SacI-GPA1F-R and cloning into pAD4M. pRS316-ADH1-REG1-
HA was constructed by QuikChange to substitute an HA tag for FLAG tag from 
pRS316-ADH1-REG1-FLAG using primer REG1-HA-F and its complement. Plasmid 
for bacterial expression of 6xHIS-MBP-Reg1 fusion protein was generated by 
ligation-independent cloning as described previously (41). REG1 was PCR-amplified 
from genomic DNA using primers REG1-MBP-F and REG1-MBP-R and annealed to 
the gapped 6XHis vector pLIC-MBP (from John Sondek, University of North 
Carolina). 
Protein Detection. Unless otherwise noted, cell pellets were harvested by 
addition of 100% trichloroacetic acid (5% final concentration), centrifuged at 3000 x 
g for 2 min, washed with 1 mL of 10 mM NaN3, and stored as a frozen cell pellet at 
−20 °C. Protein extracts were generated by glass bead lysis in trichloroacetic acid as 
described previously (22) and 35 µg total cell lysate was resolved by 10% SDS-
PAGE and immunoblotting. For immunoblotting, nitrocellulose membranes were 
probed with anti-Gpa1 at 1:1,000 (8), anti-FLAG at 1:1,000 (F1804, Sigma Aldrich), 
anti-p44/42 at 1:500 (9101L, Cell Signaling Technology), anti-G6PDH at 1:50,000 
(A9521, Sigma Aldrich), anti-HA at 1:10,000 (A190-108A, Bethyl), anti-Phospho-
AMPKα at 1:2,000 (4188, Cell Signaling), anti-protein A at 1:50,000 (P3775, Sigma 
Aldrich), and anti-MBP at 1:2,000 (sc-13914, Santa Cruz). Immunoreactive species 
were visualized by chemiluminescent detection (PerkinElmer Life Sciences) of 
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horseradish peroxidase-conjugated anti-rabbit at 1:10,000 (170-5046) or anti-mouse 
IgG at 1:10,000 (170-5047) (Bio-Rad). Blots were exposed to HyBlot Cl 
autoradiography film (Denville Scientific). Film exposures that contained unsaturated 
bands were used for analysis by densitometry using ImageJ software from National 
Institutes of Health. 
 Immunoprecipitation of Gpa1-FLAG. Plasmids pAD4M-GPA1-FLAG or 
empty vector were transformed into wild-type cells with either pRS316-ADH1-REG1-
HA or empty vector or pRS426-SAK1-TAP or empty vector. Culture growth and 
FLAG purification was conducted as described previously (16). Samples were 
resolved by 10% SDS-PAGE and immunoblotted for FLAG-, HA-, and/or TAP-fusion 
proteins. 
 TAP- and 6XHis-fusion Protein Purification and Kinase Assays. Plasmids 
pRS426-SAK1-TAP or pRS426-SAK1D277A-TAP were transformed into sak1Δ cells. 2 
L cultures were grown to early-log phase, harvested by centrifugation, washed with 
dH2O, and stored at −20 °C. All procedures were conducted at 4 °C unless noted 
otherwise. The cell pellets were lysed by glass bead agitation in lysis buffer 
containing 41.7 mM Na2HPO4 and 8.3 mM NaH2PO4 (pH 7.5), 400 mM NaCl, 10% 
glycerol, 0.1% Triton X-100 (Sigma-Aldrich), 25 mM NaF, 2 mM β-glycerophosphate, 
1 mM DTT, 1X protease inhibitor mixture tablets (Roche), and 500 µM PMSF. 
Samples were rocked for 60 min to solubilize proteins. The lysate mixture was 
subjected to microcentrifugation at 21,000 ?g for 10 min, and a final concentration 
of 1 mM CaCl2 was added to the soluble extract for binding of TAP-tagged proteins 
to 50 µl Calmodulin Affinity Resin (Agilent) for 2 h with gentle rocking.  The resin was 
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washed five times in 1 mL lysis buffer containing 1 mM CaCl2 and then eluted with 
100 µL lysis buffer containing 2 mM EGTA. Eluted protein was dialyzed with a slide-
a-lyzer mini cartridge (Pierce) into dialysis buffer containing 20 mM Tris-HCl (pH 
8.0), 100 mM NaCl, 2 mM MgCl2, and 5% glycerol. Approximately 1–5 µg of protein 
was recovered in a typical TAP purification. Recombinant 6XHis-Gpa1 and 6XHis-
MBP-Reg1 were expressed by autoinduction (43) and purified using nickel-affinity 
chromatography (46) as described previously, but without cleavage of the N-terminal 
6XHis tag. In vitro kinase assays were conducted by incubating 0.075−0.15 pmol of 
purified TAP-kinase (3-6 nM final concentration) and 12.5 pmol of recombinant Gpa1 
(0.5 µM final concentration) in 1X kinase reaction buffer described previously for 
Elm1 (45). Reactions were stopped by addition of 6X SDS-PAGE loading buffer and 
were immediately subjected to 10% SDS-PAGE. Gels were dehydrated and 
exposed to autoradiography film (HyBlot CL, Denville Scientific). 
 Steric-exclusion Chromatography of Gpa1 and Reg1. Purified 6XHis-
Gpa1 and Reg1-MBP were subjected to steric exclusion chromatography by use of 
an Akta FPLC system and a Sephacryl 26/60 S200 column (GE Healthcare). 1 nmol 
6XHis-Gpa1 and 3.25 nmol Reg1-MBP were equilibrated in 20 mM Tris (pH 8.0), 
100 mM NaCl, 5% glycerol, 1 mM DTT, 2 mM MgCl2, and 20 µM GDP. Protein was 
separated at 0.5 mL/min and collected in 7 mL fractions. A 20 µL sample from each 
fraction was separated by SDS-PAGE and probed with Gpa1 antibodies or MBP 
antibodies. 
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 Pheromone Transcriptional Reporter Assay and Quantitative Mating 
Assay. Transcriptional reporter assays (18) and mating assays (38) were conducted 
as described previously. Briefly, equal amounts of early-log phase MATa cells 
(BY4741) and MATα cells (BY4742, leu2Δ his3Δ ura3Δ lysΔ MET +) were mixed, 
filtered onto nitrocellulose membranes and incubated on YPD plates containing 2% 
or 0.05% glucose. After 4 hours of incubation, cells were resuspended and plated 
onto SCD or SD +Leu/His/Ura plates. Mating efficiency was calculated by dividing 
the number of diploid colonies by total number of cells on SCD plate. 
 Microscopy. A microfluidic device was constructed similar to the one 
described previously (11). Cells were imaged every 5 minutes for 12 hours. Image 
acquisition was done with an Olympus Spinning Disc Confocal microscope and 
image processing and analysis was done using ImageJ software.  
 
82 
Table 3.1: Strains used in Chapter III 
 
Strains Parent Description 
BY4741  MATa leu2Δ met15Δ his3Δ ura3Δ  
BY4742  MATα leu2Δ his3Δ ura3Δ lysΔ MET + 
elm1Δ BY4741 elm1Δ::KanMX4 
tos3Δ BY4741 tos3Δ::KanMX4 
sak1Δ  BY4741 sak1Δ::KanMX4 
ste2Δ BY4741 ste2Δ::KanMX4 
ste4Δ BY4741 ste4Δ::KanMX4 
sst2Δ BY4741 sst2Δ::KanMX4 
vps15Δ BY4741 vps15Δ::KanMX4 
elm1Δsak1Δ BY4741 elm1Δ::URA3 sak1Δ::KanMX4 
elm1Δtos3Δ BY4741 elm1Δ::URA3 tos3Δ::KanMX4 
sak1Δtos3Δ BY4741 sak1Δ::URA3 tos3Δ::KanMX4 
elm1Δsak1Δtos3Δ  BY4741 elm1Δ::URA3 sak1Δ::LEU2 tos3Δ::KanMX4 
reg1Δ BY4741 reg1Δ::KanMX4 
snf1Δ BY4741 snf1Δ::KanMX4 
gpr1Δ BY4741 gpr1Δ::KanMX4 
gpa2Δ BY4741 gpa2Δ::KanMX4 
rgt2Δ BY4741 rgt2Δ::KanMX4 
snf3Δ BY4741 snf3Δ::KanMX4 
rgt2Δsnf3Δ BY4741 rgt2Δ::KanMX4 snf3Δ::URA3 
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Table 3.2: Plasmids used in Chapter III 
 
Name Description Source 
pAD4M  2 µm AmpR LEU2 ADH1 promoter/terminator (1) 
pAD4M-GPA1 2 µm AmpR LEU2 ADH1 GPA1 (7) 
pLIC-6XHIS-GPA1  AmpR 6HIS-TEV-GPA1 (46) 
pLIC-REG1-MBP  AmpR REG1-TEV-MBP This Study 
pRS316-ADH1-GPA1-FLAG  CEN6 AmpR URA3 ADH1 GPA1-FLAGInternal (4) 
pRS313 CEN6 AmpR HIS3 (35) 
pRS315  CEN6 AmpR LEU2 (35) 
pRS316  CEN6 AmpR URA3 (35) 
pRS313-SAK1  CEN6 AmpR HIS3 SAK1 +/- 500bp  This Study 
pRS423-FUS1-lacZ 2 µm AmpR HIS3 FUS1-lacZ (17) 
pRS426-SAK1-TAP 2 µm AmpR URA3 SAK1-TAP (10) 
pRS426-SAK1D277A-TAP 2 µm AmpR URA3 SAK1D277A-TAP (10) 
pRS426-ADH1-TOS3-TAP 2 µm AmpR URA3 ADH1 TOS3-TAP (10) 
pRS316-REG1 CEN6 AmpR URA3 REG1 +/- 500bp This Study 
pRS316-REG1F468R CEN6 AmpR URA3 REG1F468R +/- 500bp This Study 
pAD4M-GPA1-FLAG 2 µm AmpR LEU2 ADH1 GPA1-FLAGInternal This Study 
pRS316-ADH1-REG1-HA CEN6 AmpR URA3 ADH1 REG1-HA This Study 
yCP50 CEN6 AmpR URA3  (40) 
yCP50-STE11-4 CEN6 AmpR URA3 STE11-4 (40) 
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Table 3.3: Oligonucleotide primer sequences 
 
Name Sequence 5'-3' 
SacII-SAK1-F GCCCGCGGGACAAGCTGTTGAGAGCAGGC 
SmaI-SAK1-R GCCCCGGGGCCCTCTTTAATTCCGGACG 
XhoI-REG1-F TTCACCTCGAGTCCTCCACTTCATGC 
KpnI-REG1-R TCTCGGTACCGGTGTGACACTGCCAG 
REG1-F468R-F* CCTACTAAAAATAGACATATACATCGTAATGACAGGGTGGAAC 
SmaI-ADH1-F TATCCCGGGTAGTCGACGGATCCCATG 
SacI-GPA1-R ACGAGCTCTATAATACCAATTTTTTTAAGGTTTTGCTGGATG 
REG1-HA-F* GAAAATGGAAATGACAGCAGTTACCCATACGATGTTCCAGA TTACGCTTAGGACGTCGACGGATCCGAGC 
REG1-MBP-F TACTTCCAATCCAATCGCATGTCAACAAATCTAGCAAATTACTTC 
REG1-MBP-R TTATCCACTTCCAATGCGCTACTAACTGCTGTCATTTCC 
 
*Only forward sequence shown for QuikChange primers. Mutations indicated with 
bold typeface. 
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CHAPTER IV 
 
CONCLUSIONS AND GENERAL DISCUSSION* 
 
 In this thesis my co-contributors and I demonstrated a novel role of G alpha 
phosphorylation in a GPCR-mediated signaling transduction pathway. We identified 
kinases and a regulatory phosphatase for the G protein α subunit Gpa1 that are 
required for proper pheromone signaling transduction in yeast. We characterized two 
modes of Gpa1 phosphorylation: one that is coordinated with cell-cycle changes and 
one that is regulated by glucose limitation. We found that expression of the Gpa1 
kinase Elm1 is coordinated with the cell-cycle and concomitantly Gpa1 
phosphorylation fluctuates with the cell-cycle. Gpa1 phosphorylation is highest in 
G2/M phase, which is a prerequisite for Gpa1 polyubiquitination by SCFCdc4 and 
leads to proteasomal degradation in G1 phase. Because Gpa1 is a negative 
regulator of the pathway, degradation of Gpa1 allows maximal pheromone-mediated 
signaling during G1 phase, where the genomic content is optimal for cell fusion.  
In addition, we found that Gpa1 is phosphorylated in low glucose conditions. 
We determined that kinases Sak1, Elm1, and Tos3, and phosphatase Reg1/Glc7 
regulate Gpa1 phosphorylation in low glucose conditions. Interestingly, these 
upstream kinases and phosphatase are well known to control the phosphorylation of 
                                            
* All figures contributed by Sarah T. Clement 
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glucose sensor Snf1 in low glucose conditions. We established that phosphorylation 
of Gpa1 in low glucose conditions serves to dampen the pheromone response 
pathway, in an attempt to prioritize cell survival in conditions of energy stress. 
Ongoing research in the lab includes examining other instances of signaling cross 
talk between the pheromone response pathway and other cell stress pathways, such 
as low pH or salt stress. Preliminary results indicate that other stresses also alter the 
phosphorylation of Gpa1 and support a common adaptation to prioritize signaling 
transduction during conditions of cellular stress. 
 
Conditional Gpa1 phosphorylation 
Upon the discovery that low glucose conditions induce Gpa1 phosphorylation, 
it seemed logical to test if this conditional phosphorylation led to ubiquitination in the 
same manner as Elm1-dependent cell-cycle phosphorylation and ubiquitination. In 
addition, we identified that Gpa1 is a substrate for the regulatory phosphatase Reg1. 
Thus we also examined ubiquitination in the reg1Δ mutant in which Gpa1 is hyper-
phosphorylated even in high glucose conditions.  
We monitored Gpa1 polyubiquitination in wild type, reg1Δ, elm1Δ, or elm1Δ in 
low glucose cells expressing myc-ubiquitin (proteins conjugated to myc-ubiquitin are 
degraded slowly) (3, 4) (these experiments were described in Chapter II and Fig. 
2.7). As expected, Gpa1 polyubiquitination was diminished in the absence of Elm1. 
However, in conditions where Gpa1 phosphorylation was increased, namely in 
absence of Reg1 or in low glucose, we did not see increased polyubiquitination (Fig. 
4.1A). This was surprising, as we had shown that phosphorylation was a prerequisite 
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for polyubiquitination. In addition, we compared Gpa1 polyubiquitination in the 
presence and absence of REG1 using a proteasome-deficient yeast strain, cim3–1 
(14, 15) (these experiments were described in Chapter II and Fig. 2.6). We did not 
see an increased amount of polyubiquitination in the cim3-1/reg1Δ strain compared 
to cim3-1 (Fig. 4.1B). Together, these experiments reveal that the phosphorylation of 
Gpa1 induced by low glucose and deletion of REG1 does not result in increased 
polyubiquitination of Gpa1. Thus, multiple Gpa1 phosphorylation phenotypes exist 
and may explain why different phosphorylation stimuli result in divergent outcomes.  
In order to analyze the difference in Gpa1 phosphorylation phenotypes, we 
examined electrophoretic mobility shifts of phosphorylated Gpa1 species using 
Phos-tag acrylamide, which specifically reduces the mobility of phosphorylated 
proteins (6) (Fig. 4.2). Using Phos-tag we observed multiple bands, instead of the 
typical doublet, providing evidence that Gpa1 is phosphorylated at multiple sites 
besides Ser-200 (See Fig. 2.4). Additionally, by this approach we were able to 
demonstrate differences in Gpa1 phosphorylation by cell-cycle arrest versus low 
glucose-induced phosphorylation. Therefore, these conditions, which both induce 
Gpa1 phosphorylation, are not identical and likely result in different sites of protein 
modification. This hypothesis is substantiated by preliminary mass spectrometry 
experiments conducted by Matt Torres. He has found that the primary sites of 
induced phosphorylation during G2/M cell-cycle arrest are Ser-199 and Ser-200. 
Interestingly, low glucose treatment results in phosphorylation at Ser-199, Ser-200 
and Ser-175, as well as loss of phosphorylation at Thr-154, Thr-224, and Ser-225 
compared to regular growth conditions (unpublished findings). These findings help to 
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distinguish the condition-specific sites of Gpa1 phosphorylation/dephosphorylation, 
and could account for the differences in the outcome of pheromone pathway 
signaling events.  Whereas cell-cycle dependent phosphorylation of Gpa1 lead to 
polyubiquitination and thus enhanced pathway signaling during G1 phase of the cell 
cycle, low glucose dependent phosphorylation of Gpa1 is associated with dampened 
signaling output. The mechanism of how phosphorylated Gpa1 mediates a 
dampened signal output is unclear, but the changes in 
phosphorylation/dephosphorylation point to a new binding surface that may cause 
an enhanced interaction with the receptor or Gβγ subunits to decrease signaling. 
Also, it is highly likely the Snf1-mediated glucose response pathway exerts 
regulation on other pathway components, which contributes to overall reduction in 
signaling responses. 
 It has been a challenge in these projects to design a phosho-mimetic mutant 
of Gpa1 that recapitulates the outputs we observe during Gpa1 phosphorylation 
events. The mass spectrometry data reveals the complexity of the phosphorylation 
status as sites in Gpa1 are dynamically regulated by the addition and removal of 
post-translational marks by a single stimulus. As mentioned above, modifications on 
Gpa1 could alter binding with the Gβ subunit Ste4, but characterizing this interaction 
is further complicated by post-translational modifications of Ste4 itself. Ste4 
becomes phosphorylated and mono-ubiquitinated (but not degraded) after cells are 
induced with pheromone, and these modifications plays a role in polarized growth 
(16). It is still unclear if Ste4 undergoes any modifications in the low glucose 
conditions. Future work aims to distinguish the post-translational modifications of 
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Gpa1 and Ste4 to better define how post-translational modifications lead to specific 
phenotypic signaling outputs. 
 
Signal transduction in human health and disease 
 While this research highlights the cross talk between yeast signaling 
transduction pathways, our findings are likely to translate to human signaling 
transduction pathways given the high conservation of protein signaling components. 
Because human tissue is highly specialized, it is important to distinguish that cross 
talk between any two signaling pathways can vary depending on cell type and 
cellular environments.  
 GPCR-mediated pathways are the most highly targeted signal transduction 
pathways for pharmaceuticals currently on the market. Some drugs act directly as 
agonists or antagonists to GPCRs such as beta-blockers and some exert their 
effects indirectly such as selective serotonin reuptake inhibitors. GPCRs are 
ubiquitously expressed throughout the body (10), but most pharmaceutical targets 
are in the brain and heart. In the brain, many prescription drugs target GPCR-
signaling pathways to mediate an imbalance in neurotransmitters to improve quality 
of life in psychiatric disorders such as depression or schizophrenia (1). In the heart, 
GPCRs have been targeted to improve cardiac function (12). Chronic activation of 
cardiac GPCR-mediated pathways can lead to heart failure, thus prescription drugs 
such as beta-blockers aim to antagonize signaling outputs. 
Activation of human AMPK results in many physiological changes as well. 
These include activation of fatty acid uptake and oxidation and also glucose uptake 
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in several tissues. AMPK is likely expressed in all cell types, but is present at high 
levels in tissues that regulate energy homeostasis, including the liver, heart, skeletal 
muscle, pancreas and brain (9). The consequences of AMPK activation include 
increased glycolysis in heart, inhibition of fatty acid synthesis in liver and adipocytes, 
inhibition of cholesterol synthesis and gluconeogenesis in liver, inhibition of protein 
synthesis in liver and skeletal muscle, and inhibition of insulin secretion by the 
pancreas. AMPK is a novel substrate for the treatment of type 2 diabetes (5) since 
it’s signaling cascade leads to an increase in glucose uptake that is not dependent 
upon the insulin-signaling pathway. In addition, since cancer cells have larger 
energetic requirements than non-dividing cells, targeting AMPK might be an 
attractive approach for attacking cancer (13). 
 
Conclusions 
This work revealed a link between genes that regulate the metabolic AMPK 
sensor Snf1 and Gα subunit Gpa1. By extension, these findings suggest that other 
Gα subunits are subject to conditional post-translational modifications during stress 
conditions and may serve to modulate signaling outcomes (Fig. 4.3). GPCR-
mediated and AMPK signaling pathways are highly conserved from yeast to 
humans. Importantly, conserved pathway components in both GPCR and AMPK 
pathways are implicated in a range of human diseases and ailments and some of 
these pathway components are known targets of pharmaceuticals. Since cross talk 
between concurrent signaling pathways can result in misregulated responses, future 
research is needed to design drug regimens to optimize therapeutic effectiveness. 
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Experimental Procedures 
In Vivo Ubiquitination Assays – Gpa1 polyubiquitination was detected by 
constitutive (ADH1 promoter) expression of Gpa1 in yeast harboring a temperature-
sensitive mutation (cim3-1) or by coexpression of Gpa1 and Myc-ubiquitin as 
described previously (15). For cim3-1 and isogenic wild-type cells, log-phase 
cultures were grown at the permissive temperature (25 °C) to an A600 nm of 0.5-0.6, 
followed by transition to the restrictive temperature (37 °C) for 3 h. Inducible Myc-
ubiquitin strains were grown at 30 °C to an A600 nm of 0.5-0.6, followed by addition of 
CuSO4 to 100 µM for 3 h at 30 °C as described previously (11).  
Doxycycline knockdown of TetO7 genes – A library of repressible promoter 
strains containing yeast essential genes is commonly used to study genes that 
cannot be deleted by typical methods (8). Strains in the library contain genes 
controlled by a tetracycline-repressible promoter and allow knockdown of gene 
expression. Wild type (TetO7-WT) and TetO7-PMA1 cells were grown for ~15 h in 
either untreated medium or medium containing 10 µg/mL doxycycline hyclate 
(Sigma-Aldrich). Some samples were centrifuged, washed and resuspended in 
medium containing 0.05% glucose for 5 minutes. Growth was stopped by addition of 
trichloroacetic acid (5% final concentration). 
Protein Detection. Unless otherwise noted, cell pellets were harvested by 
addition of 100% trichloroacetic acid (5% final concentration), centrifuged at 3000 xg 
for 2 min, washed with 1 mL of 10 mM NaN3, and stored as a frozen cell pellet at 
−20 °C. Protein extracts were generated by glass bead lysis in trichloroacetic acid as 
described previously (7) and 35 µg total cell lysate was resolved by 10% SDS-PAGE 
100 
and immunoblotting. For immunoblotting, nitrocellulose membranes were probed 
with anti-Gpa1 at 1:1,000 (2), anti-G6PDH at 1:50,000 (A9521, Sigma Aldrich), and 
anti-Phospho-AMPKα at 1:2,000 (4188, Cell Signaling). Immunoreactive species 
were visualized by chemiluminescent detection (PerkinElmer Life Sciences) of 
horseradish peroxidase-conjugated anti-rabbit at 1:10,000 (170-5046) (Bio-Rad). 
Blots were exposed to HyBlot Cl autoradiography film (Denville Scientific). Film 
exposures that contained unsaturated bands were used for analysis by densitometry 
using ImageJ software from National Institutes of Health. 
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